EARLY ALZHEIMER´S DISEASE
Clinical trials for EARLY ALZHEIMER´S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER´S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER´S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes pill shows promise in major Alzheimer's trial
Disease control CompletedThis large study tested whether oral semaglutide, a medication already used for type 2 diabetes, could slow the progression of early Alzheimer's disease. About 1,840 participants with mild memory problems took either the real drug or a placebo pill daily for over three years. Res…
Matched conditions: EARLY ALZHEIMER´S DISEASE
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
New pill tested to slow Alzheimer's in High-Risk group
Disease control CompletedThis study tested an oral medication called ALZ-801 in 84 people with early Alzheimer's disease who carry a specific genetic risk factor (the APOE4 gene). The main goal was to see if the drug could affect biological markers of Alzheimer's in the blood and brain over two years, an…
Matched conditions: EARLY ALZHEIMER´S DISEASE
Phase: PHASE2 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
New Alzheimer's pill shows promise in slowing cognitive decline for High-Risk group
Disease control CompletedThis Phase 3 trial tested whether an oral medication called ALZ-801 could slow Alzheimer's progression in people with early-stage disease who carry two copies of the APOE4 gene, which increases risk. 325 participants took either the drug or a placebo twice daily for 78 weeks whil…
Matched conditions: EARLY ALZHEIMER´S DISEASE
Phase: PHASE3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC